Synonym:
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
Properties:
Related Categories |
Additional Standards,
Analytical Standards,
Analytical/Chromatography,
Chromatography,
Pharmaceutical Secondary Standards,
|
grade
|
certified reference material
|
|
pharmaceutical secondary standard
|
InChI Key
|
VOVIALXJUBGFJZ-KWVAZRHASA-N
|
form
|
neat
|
format
|
neat
|
pharmacopeia traceability
|
traceable to BP 793
|
|
traceable to PhEur B1157300
|
|
traceable to USP 1078201
|
Description:
Analysis Note
These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available.
General description
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Other Notes
This product was designed, produced and verified for accuracy and stability in accordance with ISO/IEC 17025:2005 (AClass Cert AT-1467), ISO GUIDES 34:2009 (AClass Cert AR-1470).
Values of analytes vary lot to lot.
Biochem/physiol Actions
Budesonide is a second generation glucocorticoid with low systemic absorption. It is used as an anti-inflammatory agent in the treatment of asthma, rhinitis, and inflammatory bowel disease. It inhibits the expression of chemokine mRNA and production of eotaxin and RANTES protein in primary human bronchial epithelial cells. Budesonide is currently in clinical trials for the prevention of lung cancer. It shows inhibitory effects on benzo[a]pyrene-induced carcinogenesis of the lung in mice.
Footnote
To see an example of a Certificate of Analysis for this material enter LRAA8997 in the slot below. This is an example certificate only and may not be the lot that you receive.
Safety:
RIDADR
NONH for all modes of transport